TAT Technologies Reports Second Quarter 2025 Results
Rhea-AI Summary
TAT Technologies (NASDAQ: TATT) reported strong Q2 2025 results with significant growth across key metrics. Revenue increased 18.0% to $43.1 million, while net income rose 31.5% to $3.4 million compared to Q2 2024. The company's gross profit grew 35.6% to $10.8 million, representing 25.1% of revenues.
Notable achievements include a $45 million capital raise and growth in LTA and backlog value by $85 million to $524 million. Operating cash flow improved significantly, generating $6.9 million in Q2 2025 compared to $(4.1) million used in Q2 2024. The company's adjusted EBITDA increased 39.2% to $6.1 million, representing 14.0% of revenues.
Management expressed confidence in sustaining growth and expanding profit margins through 2026, citing strong order intake and increasing MRO activity.
[ "Revenue growth of 18.0% YoY to $43.1 million in Q2 2025", "Net income increased 31.5% to $3.4 million", "Successful $45 million capital raise strengthening balance sheet", "LTA and backlog value grew by $85 million to $524 million", "Operating cash flow improved to $6.9 million from $(4.1) million in Q2 2024", "Gross profit margin expanded to 25.1% from 21.9% YoY" ]Positive
- None.
Negative
- Slowdown reported in MRO activity, though beginning to re-accelerate
Insights
TAT Technologies delivered strong Q2 2025 results with 18% revenue growth, 62.2% increase in operating income, and significant improvement in cash flow.
TAT Technologies has delivered impressive Q2 2025 results, demonstrating substantial growth across key financial metrics. Revenue increased by
The company's profitability metrics show a strong upward trajectory, with net income rising
Beyond quarterly performance, TAT's long-term prospects are bolstered by an
TAT's ability to outperform the broader aerospace MRO market despite noted slowdowns speaks to the effectiveness of their diversified business model across trading and MRO/OEM segments. With management reporting a recent reacceleration in MRO intake and continued new contract wins, including for the 777APU, the company appears well-positioned to maintain growth momentum through 2026 while expanding profit margins.
NETANYA,
Financial highlights for the second quarter of 2025:
- Revenues increased by
18.0% to compared to$43.1 million for the second quarter of 2024. For the first half of 2025 revenues increased by$36.5 million 20.7% to compared to$85.2 million in the first half of 2024.$70.6 million - Gross profit increased by
35.6% to compared to$10.8 million for the second quarter of 2024 ($8.0 million 25.1% of revenues in Q2\25 compared to21.9% of revenues in Q2\24). For the first half of 2025 gross profit increased by38.1% to compared to$20.8 million in the first half of 2024 ($15.1 million 24.4% of revenues in H1\25 compared to21.3% of revenues in H1\24) - Operating Income increased by
62.2% to compared to$4.4 million for the second quarter of 2024, ($2.7 million 10.3% of revenues in Q2\25 compared to7.5% of revenues in Q2\24). For the first half of 2025 operating income increased by74.1% to compared to$8.6 million in the first half of 2024 ($4.9 million 10.1% of revenues in H1\25 compared to7.0% of revenues in H1\24). - Net Income increased by
31.5% to compared to$3.4 million for the second quarter of 2024. For the first half of 2025 net income increased by$2.6 million 53.5% to compared to$7.2 million in the first half of 2024.Adjusted EBITDA increased by$4.7 million 39.2% to ($6.1 million 14.0% of revenues) compared to ($4.3 million 11.9% of revenues) for the second quarter of 2024. Adjusted EBITDA for the first half of 2025 increased by47.1% to compared to$11.8 million in the first half of 2024 ($8.0 million 13.9% of revenues in H1\25 compared to11.4% in H1\24). - Cash flow provided by operating activities for the three and six months ended June 30, 2025, was
and$6.9 million , respectively, compared to cash flows used in operating activities of$1.9 million and$(4.1) million for the three and six months ended June 30, 2024, respectively.$(7.6) million
Mr. Igal Zamir, TAT's CEO and President, commented: "TAT Technologies delivered another quarter of organic growth and improved profitability, with second quarter revenue growing
"In addition to the double-digit revenue growth, the value of our LTA and backlog grew by approximately
Mr. Zamir continued, "This quarter, we successfully completed a capital raise of
With the growing LTA value and backlog, strong order intake, and the ramp up in MRO activity, we are confident in our ability to sustain growth and expand profit margins through 2026," concluded Mr. Zamir.
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, the Company also presents Adjusted EBITDA. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors with a more complete understanding of the Company's underlying operational results, trends and performance. Adjusted EBITDA is calculated as net income excluding the impact of: the Company's share in results of affiliated companies, share-based compensation, taxes on income, financial (expenses) income, net, and depreciation and amortization. Adjusted EBITDA, however, should not be considered as an alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA below.
About TAT Technologies LTD
We are a leading provider of solutions and services to the aerospace and defense industries. We operate four operational units: (i) original equipment manufacturing ("OEM") of heat transfer solutions and aviation accessories through our Kiryat Gat facility (TAT Israel); (ii) maintenance repair and overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through our subsidiary Limco Airepair Inc. ("Limco"); (iii) MRO services for aviation components through our subsidiary, Piedmont Aviation Component Services LLC ("Piedmont") (mainly Auxiliary Power Units ("APUs") and landing gear); and (iv) overhaul and coating of jet engine components through our subsidiary, Turbochrome Ltd. ("Turbochrome").
TAT's activities in the area of OEM of heat transfer solutions and aviation accessories through TAT Israel primarily include the design, development and manufacture of (i) a broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft and ground applications; and (iii) a variety of mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.
TAT's activities in the area of MRO and OEM of heat transfer solutions include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT's Limco subsidiary operates a Federal Aviation Administration ("FAA")-certified repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers and the military.
TAT's activities in the area of MRO services for aviation components include the MRO of APUs and landing gear. TAT's Piedmont subsidiary operates an FAA-certified repair station, which provides aircraft component MRO services for airlines, air cargo carriers, maintenance service centers and the military.
TAT's activities in the area of jet engine overhaul through its Turbochrome facility includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.
Contact:
Mr. Eran Yunger
Director of IR
erany@tat-technologies.com
Safe Harbor for Forward-Looking Statements
This press release and/or this report contains "forward-looking statements" within the meaning of
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||||
June 30, | December 31, | |||
2025 | 2024 | |||
ASSETS | ||||
CURRENT ASSETS: | ||||
Cash and cash equivalents | $ 43,126 | $ 7,129 | ||
Short-term bank deposits | 57 | - | ||
Accounts receivable, net of allowance for credit losses of and | 32,266 | 29,697 | ||
Inventory | 76,414 | 68,540 | ||
Prepaid expenses and other current assets | 6,610 | 7,848 | ||
Total current assets | 158,473 | 113,214 | ||
NON-CURRENT ASSETS: | ||||
Property, plant and equipment, net | 44,646 | 41,576 | ||
Operating lease right of use assets | 3,475 | 2,282 | ||
Intangible assets, net | 1,558 | 1,553 | ||
Investment in affiliates | 4,188 | 2,901 | ||
Funds in respect of employee rights upon retirement | 709 | 654 | ||
Deferred income taxes | 295 | 877 | ||
Restricted deposit | 291 | 305 | ||
Total non-current assets | 55,162 | 50,148 | ||
Total assets | $ 163,362 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
CURRENT LIABILITIES: | ||||
Current maturities of long-term loans | $ 2,088 | $ 2,083 | ||
Short-term loans | - | 4,350 | ||
Accounts payable | 15,564 | 12,158 | ||
Accrued expenses and other | 15,273 | 18,594 | ||
Current maturities of operating lease liabilities | 993 | 939 | ||
Total current liabilities | 33,918 | 38,124 | ||
NON-CURRENT LIABILITIES: | ||||
Long-term loans | 10,310 | 10,938 | ||
Liability in respect of employee rights upon retirement | 1,098 | 986 | ||
Operating lease liabilities | 2,528 | 1,345 | ||
Total non-current liabilities | 13,936 | 13,269 | ||
COMMITMENTS AND CONTINGENCIES (NOTE 4) | - | - | ||
Total liabilities | 47,854 | 51,393 | ||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||
| |||
SHAREHOLDERS' EQUITY: | |||
Ordinary shares of Authorized: 15,000,000 shares at June 30, 2025 and 13,000,000 at December 31, 2024; Issued: 13,161,762 and 11,214,831 shares at June 30, 2025 and at December 31, 2024, respectively; Outstanding: 12,887,289 and 10,940,358 shares at June 30, 2025 and at December 31, 2024, respectively | - | - | |
Additional paid-in capital | 135,578 | 89,697 | |
Treasury stock at cost | (2,088) | (2,088) | |
Accumulated other comprehensive income (loss) | 600 | (76) | |
Retained earnings | 31,691 | 24,436 | |
Total shareholders' equity | 165,781 | 111,969 | |
Total liabilities and shareholders' equity | $ 213,635 | $ 163,362 | |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||
Three months ended | Six months ended | ||||||
June 30, June 30, | |||||||
2025 | 2024 | 2025 | 2024 | ||||
Revenues: | |||||||
Products | $ 12,463 | $ 11,732 | $ 23,667 | ||||
Services | 30,641 | 24,793 | 60,059 | 46,946 | |||
43,104 | 36,525 | 85,246 | 70,613 | ||||
Cost of goods: | |||||||
Products | 9,112 | 7,673 | 17,443 | 16,659 | |||
Services | 23,167 | 20,868 | 47,024 | 38,904 | |||
32,279 | 28,541 | 64,467 | 55,563 | ||||
Gross profit | 10,825 | 7,984 | 20,779 | 15,050 | |||
Operating expenses: | |||||||
Research and development, net | 240 | 343 | 564 | 620 | |||
Selling and marketing | 2,185 | 1,993 | 4,113 | 3,653 | |||
General and administrative | 3,965 | 2,916 | 7,497 | 6,225 | |||
Other income | - | (2) | - | (390) | |||
6,390 | 5,250 | 12,174 | 10,108 | ||||
Operating income | 4,435 | 2,734 | 8,605 | 4,942 | |||
Interest expenses | (324) | (413) | (659) | (763) | |||
Other financial income (expenses), net | (776) | 106 | (499) | 7 | |||
Income before taxes on income (taxes benefit) | 3,335 | 2,427 | 7,447 | 4,186 | |||
Provision for taxes on income (taxes benefit) | 211 | 44 | 803 | (109) | |||
Profit before share of equity investment | 3,124 | 2,383 | 6,644 | 4,295 | |||
Share in profits of equity investment of affiliated companies | 318 | 234 | 611 | 432 | |||
Net income | $ 3,442 | $ 2,617 | $ 4,727 | ||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||
Earnings per share | |||||||
Basic | $ 0.26 | $ 0.46 | |||||
Diluted | $ 0.25 | $ 0.44 | |||||
Weighted average number of shares outstanding | |||||||
Basic | 11,447,986 | 10,394,654 | 11,196,992 | 10,386,859 | |||
Diluted | 11,666,309 | 10,561,420 | 11,409,488 | 10,722,153 | |||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Net income | $ 3,442 | $ 2,617 | $ 7,255 | $ 4,727 | ||||
Other comprehensive income (loss), net | ||||||||
Net unrealized losses from derivatives | - | - | - | (27) | ||||
Change in foreign currency translation adjustments | 148 | 164 | 676 | 164 | ||||
Total comprehensive income | $ 3,590 | $ 2,781 | ||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY | ||||||||||||||||||
Share capital | Accumulated | |||||||||||||||||
Number of shares issued | Amount | Additional paid-in capital | other comprehensive income (loss) | Treasury shares | Retained earnings | Total equity | ||||||||||||
BALANCE AT DECEMBER 31, 2023 | 10,377,085 | $ 3,140 | $ 76,335 | $ 27 | $ (2,088) | $ 13,269 | $ 90,683 | |||||||||||
CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2024: | ||||||||||||||||||
Comprehensive income | - | - | - | 137 | - | 4,727 | 4,864 | |||||||||||
Exercise of option | 49,109 | 12 | (12) | - | - | - | - | |||||||||||
Share based compensation | - | - | 189 | - | - | - | 189 | |||||||||||
BALANCE AT JUNE 30, 2024 | 10,426,194 | 3,152 | 76,512 | 164 | (2,088) | 17,996 | 95,736 | |||||||||||
BALANCE AT DECEMBER 31, 2024 | 11,214,831 | - | 89,697 | (76) | (2,088) | 24,436 | 111,969 | |||||||||||
CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2025: | ||||||||||||||||||
Comprehensive income | - | - | - | 676 | - | 7,255 | 7,931 | |||||||||||
Exercise of option | 79,633 | - | - | - | - | - | - | |||||||||||
Issuance of common shares on public offering, net of issuance costs of | 1,625,000 | - | 39,415 | - | - | - | 39,415 | |||||||||||
Exercise of the underwriters' option on public offering, net of issuance costs of | 242,298 | - | 5,953 | - | - | - | 5,953 | |||||||||||
Share based compensation | - | - | 513 | - | - | - | 513 | |||||||||||
BALANCE AT JUNE 30, 2025 | 13,161,762 | $ - | $ 135,578 | $ 600 | $ (2,088) | $ 31,691 | $ 165,781 | |||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY | ||||||||||||||||
| ||||||||||||||||
Share capital | Accumulated | |||||||||||||||
Number of shares issued | Amount | Additional paid-in capital | other comprehensive income | Treasury shares | Retained earnings | Total equity | ||||||||||
BALANCE AT MARCH 31, 2024 | 10,382,637 | $ 3,141 | $ 76,376 | $ - | $ (2,088) | $ 15,379 | $ 92,808 | |||||||||
CHANGES DURING THE 3 MONTHS ENDED JUNE | ||||||||||||||||
Comprehensive income | - | - | - | 164 | - | 2,617 | 2,781 | |||||||||
Exercise of option | 43,557 | 11 | (12) | - | - | - | (1) | |||||||||
Share based compensation | - | - | 148 | - | - | - | 148 | |||||||||
BALANCE AT JUNE 30, 2024 | 10,426,194 | 3,152 | 76,512 | 164 | (2,088) | 17,996 | 95,736 | |||||||||
BALANCE AT MARCH 31, 2025 | 11,214,831 | - | 89,919 | 452 | (2,088) | 28,249 | 116,532 | |||||||||
CHANGES DURING THE 3 MONTHS ENDED JUNE 30, 2025: | ||||||||||||||||
Comprehensive income | - | - | - | 148 | - | 3,442 | 3,590 | |||||||||
Exercise of stock option | 79,633 | - | - | - | - | - | - | |||||||||
Issuance of common shares on public offering, net of issuance costs of | 1,625,000 | - | 39,415 | - | - | - | 39,415 | |||||||||
Exercise of the underwriters' option on public offering, net of issuance costs of | 242,298 | - | 5,953 | - | - | - | 5,953 | |||||||||
Share based compensation | - | - | 291 | - | - | - | 291 | |||||||||
BALANCE AT JUNE 30, 2025 | 13,161,762 | $ - | $ 135,578 | $ 600 | $ (2,088) | $ 31,691 | ||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
Three Months Ended June 30, |
Six Months Ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
Net income | $ 3,442 | $ 2,617 | $ 7,255 | $ 4,727 | |||
Adjustments to reconcile net income to net cash used in operating activities: | |||||||
Depreciation and amortization | 1,208 | 1,431 | 2,513 | 2,805 | |||
Non-cash financial (income) expenses | 600 | (276) | 508 | (486) | |||
Change in allowance for credit losses | 75 | 40 | 25 | 40 | |||
Share in profits of equity investment of affiliated companies | (318) | (234) | (611) | (432) | |||
Share based compensation | 291 | 148 | 513 | 189 | |||
Gain on disposal of property, plant and equipment | - | (1) | - | (355) | |||
Deferred income taxes, net | 63 | 306 | 582 | (103) | |||
Changes in operating assets and liabilities: | |||||||
Decrease (increase) in trade accounts receivable | 882 | (5,430) | (2,594) | (6,250) | |||
Decrease (increase) in prepaid expenses and other current assets | 1,697 | (129) | 1,183 | (283) | |||
Increase in inventory | (3,434) | (2,906) | (7,295) | (5,543) | |||
Increase (decrease) in trade accounts payable | 2,972 | (209) | 3,406 | (909) | |||
Decrease (increase) in accrued expenses and other | (529) | 543 | (3,571) | (1,047) | |||
Net cash provided by (used in) operating activities | 6,949 | (4,100) | 1,914 | (7,647) | |||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Proceeds from sale of property and equipment | - | - | - | 1,306 | |||
Purchase of property and equipment | (3,305) | (978) | (6,167) | (1,967) | |||
Net cash used in investing activities | (3,305) | (978) | (6,167) | (661) | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Repayments of long-term loans | (516) | (510) | (1,087) | (950) | |||
Proceeds from issuance of ordinary shares and exercise of the underwriters' option | 48,550 | (1) | 48,550 | - | |||
Issuance costs of ordinary shares and exercise of the underwriters' option | (2,820) | - | (2,820) | - | |||
Net change in short term loans from banks | (10,719) | 4,668 | (4,350) | 668 | |||
Net cash provided by (used in) financing activities | 34,495 | 4,157 | 40,293 | (282) | |||
Net increase (decrease) in cash and cash equivalents and restricted cash | 38,139 | (921) | 36,040 | (8,590) | |||
Cash and cash equivalents and restricted cash at beginning of period | 5,335 | 9,273 | 7,434 | 16,942 | |||
Cash and cash equivalents and restricted cash at the end of period | $ 43,474 | $ 8,352 | $ 43,474 | $ 8,352 | |||
Supplementary information on investing and financing activities not involving cash flows: | |||||||
Additions of operating lease right-of-use assets and operating lease liabilities | $ 245 | $ 1,835 | $ 590 | ||||
Reclassification between inventory and property, plant and equipment | - | - | 579 | 60 | |||
Unpaid issuance costs of ordinary shares and exercise of the underwriters' option | 362 | - | 362 | - | |||
Supplemental disclosure of cash flow information: | |||||||
Interest paid | 249 | 410 | 516 | 852 | |||
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED) ( | |||||||||||
Three months ended | Six months ended | ||||||||||
June 30, | June 30, | ||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||
Net income | |||||||||||
Adjustments: | |||||||||||
Share in results and sale of equity investment of affiliated companies | (318) | (234) | (611) | (432) | |||||||
Taxes on income (tax benefit) | 211 | 44 | 803 | (109) | |||||||
Financial expenses, net | 1,100 | 306 | 1,158 | 756 | |||||||
Depreciation and amortization | 1,328 | 1,468 | 2,691 | 2,898 | |||||||
Share based compensation | 291 | 148 | 513 | 189 | |||||||
Adjusted EBITDA | |||||||||||
View original content:https://www.prnewswire.com/news-releases/tat-technologies-reports-second-quarter-2025-results-302526872.html
SOURCE TAT Technologies Ltd.